జర్నల్ ఆఫ్ ఫార్మాస్యూటికల్ కేర్ & హెల్త్ సిస్టమ్స్
అందరికి ప్రవేశం

నైరూప్య

InforMatrix Aromatase Inhibitors in Breastcancer

Janknegt R

The InforMatrix method was applied to aromatase inhibitors. The following selection criteria were used: clinical efficacy, safety, tolerability, ease of use (from a patient’s perspective), applicability (from a caregiver’s perspective) and cost. All three available aromatase inhibitors were included: anastrozole, letrozole and exemestane. The InforMatrix method provides the user with all relevant clinical information concerning the medicines. By assigning a weight to both the selection criteria and judging the performance of the medicines on each criterion a personal selection of the most suitable medicines is made, which serves as the starting point for a concrete discussion in the formulary committee.